Almirall to appoint Jon U. Garay Alonso CFO, effective August 2025
Almirall nombrará a Jon U. Garay Alonso CFO a partir de agosto de 2025
Intel ID : 411532
Relevant Documents
| Notice / Relevant Fact | 06 Mar 2025 | Almirall_Hecho_Relevante_2025.pdf | ES |
|
| Intel ID | 411532 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Almirall
(31 Dec 2022) |
Revenue: EUR 895,52m EBITDA: EUR 187,28m Net Debt: EUR 5.791,57m People: 1846 |
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|
| Type |
|
|
| Intel Grade |
 |
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.